Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $77.94M | $130.33M | 20.95% | +$52.39M |
| Geron Corporation(GERN) | 10,715,620 | 10,475,675 | -239,945 | $22.61M | $34.57M | 5.56% | +$11.96M |
| Iovance Biotherapeutics, Inc.(IOVA) | 3,289,470 | 2,200,000 | -1,089,470 | $26.74M | $32.60M | 5.24% | +$5.86M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 0 | 1,516,183 | +1,516,183 | $0 | $23.90M | 3.84% | +$23.90M |
| iTeos Therapeutics, Inc. | 1,745,943 | 1,745,943 | 0 | $19.12M | $23.81M | 3.83% | +$4.70M |
| Sutro Biopharma, Inc.(STRO) | 0 | 4,096,619 | +4,096,619 | $0 | $23.15M | 3.72% | +$23.15M |
| Crinetics Pharmaceuticals Inc. | 478,234 | 480,588 | +2,354 | $17.02M | $22.50M | 3.62% | +$5.48M |
| Olema Pharmaceuticals, Inc.(OLMA) | 1,857,136 | 1,953,690 | +96,554 | $26.06M | $22.12M | 3.56% | -$3.94M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 40,910 | 61,399 | +20,489 | $9.47M | $16.40M | 2.64% | +$6.93M |
| Natera, Inc.(NTRA) | 0 | 172,413 | +172,413 | $0 | $15.77M | 2.54% | +$15.77M |
| Werewolf Therapeutics, Inc.(HOWL) | 2,388,011 | 2,388,011 | 0 | $9.22M | $15.47M | 2.49% | +$6.26M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 294,576 | 296,050 | +1,474 | $17.79M | $14.87M | 2.39% | -$2.92M |
| Avadel Pharmaceuticals PLCADR | 664,986 | 871,149 | +206,163 | $9.39M | $14.71M | 2.37% | +$5.32M |
| Insmed Incorporated(INSM) | 528,150 | 530,794 | +2,644 | $16.37M | $14.40M | 2.32% | -$1.97M |
| ALX Oncology Holdings Inc.(ALXO) | 1,264,759 | 1,268,471 | +3,712 | $18.83M | $14.14M | 2.27% | -$4.69M |
| Viking Therapeutics, Inc.(VKTX) | 325,284 | 150,000 | -175,284 | $6.05M | $12.30M | 1.98% | +$6.25M |
| Intellia Therapeutics, Inc.(NTLA) | 382,598 | 432,598 | +50,000 | $11.67M | $11.90M | 1.91% | +$235.4K |
| REGENXBIO Inc.(RGNX) | 549,078 | 549,078 | 0 | $9.86M | $11.57M | 1.86% | +$1.71M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 245,590 | +245,590 | $0 | $11.47M | 1.84% | +$11.47M |
| Morphic Holding Inc | 323,742 | 325,333 | +1,591 | $9.35M | $11.45M | 1.84% | +$2.10M |
| 89Bio Inc | 0 | 967,742 | +967,742 | $0 | $11.26M | 1.81% | +$11.26M |
| Viridian Therapeutics, Inc.(VRDN) | 100,000 | 614,010 | +514,010 | $2.18M | $10.75M | 1.73% | +$8.57M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 1,137,108 | +1,137,108 | $0 | $10.73M | 1.73% | +$10.73M |
| Xeris Biopharma Holdings Inc | 3,847,232 | 4,166,496 | +319,264 | $9.04M | $9.21M | 1.48% | +$167.0K |
| Axsome Therapeutics, Inc.(AXSM) | 93,387 | 114,127 | +20,740 | $7.43M | $9.11M | 1.46% | +$1.67M |
| Kalvista Pharmaceuticals Inc | 0 | 760,722 | +760,722 | $0 | $9.02M | 1.45% | +$9.02M |
| Revolution Medicines, Inc.(RVMD) | 273,408 | 273,217 | -191 | $7.84M | $8.81M | 1.42% | +$964.4K |
| Verve Therapeutics, Inc | 638,163 | 638,163 | 0 | $8.90M | $8.47M | 1.36% | -$421.2K |
| Amicus Therapeutics Inc. COM | 715,883 | 718,970 | +3,087 | $10.16M | $8.47M | 1.36% | -$1.69M |
| Akero Therapeutics Inc | 0 | 332,924 | +332,924 | $0 | $8.41M | 1.35% | +$8.41M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,095,912 | 5,095,912 | 0 | $4.04M | $8.05M | 1.29% | +$4.01M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 441,259 | +441,259 | $0 | $8.05M | 1.29% | +$8.05M |
| Repare Therapeutics, Inc. | 1,639,849 | 1,639,849 | 0 | $11.97M | $7.72M | 1.24% | -$4.25M |
| Relay Therapeutics, Inc.(RLAY) | 832,017 | 832,017 | 0 | $9.16M | $6.91M | 1.11% | -$2.25M |
| Disc Medicine, Inc.(IRON) | 50,000 | 110,779 | +60,779 | $2.89M | $6.90M | 1.11% | +$4.01M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 1,340,960 | +1,340,960 | $0 | $4.63M | 0.74% | +$4.63M |
| Immatics NV | 0 | 395,237 | +395,237 | $0 | $4.15M | 0.67% | +$4.15M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 1,971,402 | +1,971,402 | $0 | $3.90M | 0.63% | +$3.90M |
| Cymabay Therapeutics Inc | 611,181 | 0 | -611,181 | $14.44M | $0 | — | -$14.44M |
| Harpoon Therapeutics, Inc. | 319,670 | 0 | -319,670 | $3.63M | $0 | — | -$3.63M |
| Inozyme Pharma Inc. | 323,813 | 0 | -323,813 | $1.38M | $0 | — | -$1.38M |
| Karuna Therapeutics Inc | 53,279 | 0 | -53,279 | $16.86M | $0 | — | -$16.86M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 70,000 | 0 | -70,000 | $639.1K | $0 | — | -$639.1K |
| Structure Therapeutics Inc.ADS | 230,696 | 0 | -230,696 | $9.40M | $0 | — | -$9.40M |